Matrix Pharmaceutical Inc.

Known as: matrix 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2015
01219942015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
UNLABELLED The HIV-1 Gag polyprotein precursor composed of the matrix (MA), capsid (CA), nucleocapsid (NC), and p6 domains… (More)
Is this relevant?
Review
2014
Review
2014
Incorporation of the viral envelope (Env) glycoprotein is a critical requirement for the production of infectious HIV-1 particles… (More)
Is this relevant?
2013
2013
The HIV-1 Vpu is required for efficient virus particle release from the plasma membrane and intracellular CD4 degradation in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Equine influenza (EI) virus (H3N8) was identified in the Australian horse population for the first time in August 2007. The… (More)
  • table 1
  • table 2
  • table 2
  • table 2
  • figure 3
Is this relevant?
2009
2009
Following entry, uncoating, and reverse transcription, a number of cellular proteins become associated with the Human… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
In retroviruses, the late (L) domain has been defined as a conserved motif in the Gag polyprotein precursor that, when mutated… (More)
Is this relevant?
2004
2004
To elucidate the role of the C-terminal portion of Gag in the incorporation of human immunodeficiency virus type 1 (HIV-1) Gag… (More)
Is this relevant?
1999
1999
We previously characterized mutations in the human immunodeficiency virus type 1 matrix (MA) protein that displayed reduced… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The matrix (MA) protein of human immunodeficiency virus type 1 (HIV-1) forms an inner coat directly underneath the lipid envelope… (More)
Is this relevant?